Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
This grant program supports quality improvement (QI) projects that aim to improve the management of adverse events related to ALK tyrosine kinase inhibitors (TKIs) and enhance quality of life for patients with metastatic ALK-positive non-small cell lung cancer (NSCLC). Proposals that adopt a patient-centered and pragmatic approach will be prioritized, with an emphasis on improving treatment adherence, symptom management, and overall wellbeing within real-world clinical settings.
Característiques principals
  • Clinical Area of Interest: Oncology - Lung

  • General Area of Interest:
    - Development and implementation of educational tools and resources for patients, caregivers, and healthcare professionals.
    - Implementation of practical, non-pharmacological strategies already used or supported in clinical practice.
    - Design and integration of monitoring systems, such as patient-reported outcome measures or digital tools.
    • Lloc de presentació
    HMRIB and PSMAR staff who need more information should contact:
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Júlia Vidal: [email protected] Ext.: 1736
    Convocatòria (URL)
    https://cdn.pfizer.com/pfizercom/2026-02/2026-Onc-Spain-Lung-QI.pdf
    Requisits
  • The geographical scope is limited to Spain.
  • Eligible professionals include medical, nursing, allied health, and/or pharmacy professional schools.
  • Eligible institutions include healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
  • Only organizations can receive grants; individuals are not eligible.
  • Collaborations are encouraged, both within an institution and across multiple organizations, provided all partners have relevant roles and the requesting organization plays a key role.
  • The applicant must be the project/program lead—or an authorized designee—and must be an employee or contractor of the requesting organization.
    • Dotació
    €40,000
    Durada
    18 months

    Arxius

    Arxiu
    2026-Onc-Spain-Lung-QI.pdf